SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001144204-19-048126
Filing Date
2019-10-11
Accepted
2019-10-11 16:12:28
Documents
2
Group Members
PETER KOLCHINSKYRA CAPITAL HEALTHCARE FUND, L.P.

Document Format Files

Seq Description Document Type Size
1 SC 13D/A tv530997_sc13da.htm SC 13D/A 64915
2 EXHIBIT 99.2 tv530997_ex99-2.htm EX-99.2 83090
  Complete submission text file 0001144204-19-048126.txt   149550
Mailing Address 200 BERKELEY STREET, 18TH FLOOR BOSTON MA 02116
Business Address 200 BERKELEY STREET, 18TH FLOOR BOSTON MA 02116 617-778-2500
RA CAPITAL MANAGEMENT, LLC (Filed by) CIK: 0001346824 (see all company filings)

IRS No.: 830406777 | State of Incorp.: MA | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 87 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140
Business Address 87 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140 (617) 401-4060
Ra Pharmaceuticals, Inc. (Subject) CIK: 0001481512 (see all company filings)

IRS No.: 262908274 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-89680 | Film No.: 191148280
SIC: 2834 Pharmaceutical Preparations